{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:31:06Z","timestamp":1707525066443},"reference-count":25,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,6,27]]},"DOI":"10.7759\/cureus.41051","type":"journal-article","created":{"date-parts":[[2023,6,27]],"date-time":"2023-06-27T21:56:21Z","timestamp":1687902981000},"source":"Crossref","is-referenced-by-count":0,"title":["Is There a Predictable Cost-Benefit Ratio in Preeclampsia?"],"prefix":"10.7759","author":[{"given":"Dogukan","family":"Ozkan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Betul","family":"Tokgoz Cakir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ceren","family":"Polat Kamaci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Merve","family":"Ozkan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cantekin","family":"Iskender","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Omer","family":"Tapisiz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yaprak","family":"Engin-\u00dcst\u00fcn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0036171","article-title":"Hypertension in women of reproductive age in the United States: NHANES 1999-2008","volume":"7","author":"Bateman BT","year":"2012","unstructured":"Bateman BT, Shaw KM, Kuklina EV, Callaghan WM, Seely EW, Hern\u00e1ndez-D\u00edaz S. Hypertension in women of reproductive age in the United States: NHANES 1999-2008. PLoS One. 2012, 7:e36171. 10.1371\/journal.pone.0036171","journal-title":"PLoS One"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1177\/2050312119843700","article-title":"Hypertension in pregnancy: pathophysiology and treatment","volume":"7","author":"Braunthal S","year":"2019","unstructured":"Braunthal S, Brateanu A. Hypertension in pregnancy: pathophysiology and treatment. SAGE Open Med. 2019, 7:2050312119843700. 10.1177\/2050312119843700","journal-title":"SAGE Open Med"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1097\/AOG.0000000000003891","article-title":"Gestational Hypertension and Preeclampsia: ACOG Practice Bulletin, Number 222","volume":"135","year":"2020","unstructured":"Gestational Hypertension and Preeclampsia. ACOG Practice Bulletin, Number 222. Obstet Gynecol. 2020, 135:e237-60. 10.1097\/AOG.0000000000003891","journal-title":"Obstet Gynecol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(10)60279-6","article-title":"Pre-eclampsia","volume":"376","author":"Steegers EA","year":"2010","unstructured":"Steegers EA, von Dadelszen P, Duvekot JJ, Pijnenborg R. Pre-eclampsia. Lancet. 2010, 376:631-44. 10.1016\/S0140-6736(10)60279-6","journal-title":"Lancet"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1097\/HJH.0b013e3282f1a953","article-title":"Non-proteinuric pre-eclampsia: a novel risk indicator in women with gestational hypertension","volume":"26","author":"Homer CS","year":"2008","unstructured":"Homer CS, Brown MA, Mangos G, Davis GK. Non-proteinuric pre-eclampsia: a novel risk indicator in women with gestational hypertension. J Hypertens. 2008, 26:295-302. 10.1097\/HJH.0b013e3282f1a953","journal-title":"J Hypertens"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.bpobgyn.2011.01.002","article-title":"Early prediction and prevention of pre-eclampsia","volume":"25","author":"Leslie K","year":"2011","unstructured":"Leslie K, Thilaganathan B, Papageorghiou A. Early prediction and prevention of pre-eclampsia. Best Pract Res Clin Obstet Gynaecol. 2011, 25:343-54. 10.1016\/j.bpobgyn.2011.01.002","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1055\/s-0029-1223285","article-title":"Increased neutrophil numbers account for leukocytosis in women with preeclampsia","volume":"26","author":"Canzoneri BJ","year":"2009","unstructured":"Canzoneri BJ, Lewis DF, Groome L, Wang Y. Increased neutrophil numbers account for leukocytosis in women with preeclampsia. Am J Perinatol. 2009, 26:729-32. 10.1055\/s-0029-1223285","journal-title":"Am J Perinatol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1159\/000009973","article-title":"Comparison of the differential distribution of leukocytes in preeclampsia versus uncomplicated pregnancy","volume":"45","author":"Lurie S","year":"1998","unstructured":"Lurie S, Frenkel E, Tuvbin Y. Comparison of the differential distribution of leukocytes in preeclampsia versus uncomplicated pregnancy. Gynecol Obstet Invest. 1998, 45:229-31. 10.1159\/000009973","journal-title":"Gynecol Obstet Invest"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejogrb.2013.12.036","article-title":"Significance of the platelet distribution width as a severity marker for the development of preeclampsia","volume":"175","author":"Yang SW","year":"2014","unstructured":"Yang SW, Cho SH, Kwon HS, Sohn IS, Hwang HS. Significance of the platelet distribution width as a severity marker for the development of preeclampsia. Eur J Obstet Gynecol Reprod Biol. 2014, 175:107-11. 10.1016\/j.ejogrb.2013.12.036","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1111\/jog.12433","article-title":"Could mean platelet volume in late first trimester of pregnancy predict intrauterine growth restriction and pre-eclampsia?","volume":"40","author":"Kanat-Pektas M","year":"2014","unstructured":"Kanat-Pektas M, Yesildager U, Tuncer N, Arioz DT, Nadirgil-Koken G, Yilmazer M. Could mean platelet volume in late first trimester of pregnancy predict intrauterine growth restriction and pre-eclampsia?. J Obstet Gynaecol Res. 2014, 40:1840-5. 10.1111\/jog.12433","journal-title":"J Obstet Gynaecol Res"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.jri.2013.05.003","article-title":"If we know so much about preeclampsia, why haven't we cured the disease?","volume":"99","author":"Roberts JM","year":"2013","unstructured":"Roberts JM, Bell MJ. If we know so much about preeclampsia, why haven't we cured the disease?. J Reprod Immunol. 2013, 99:1-9. 10.1016\/j.jri.2013.05.003","journal-title":"J Reprod Immunol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/S1665-2681(19)31836-8","article-title":"AST to platelet ratio index (APRI) for the noninvasive evaluation of liver fibrosis","volume":"7","author":"Loaeza-del-Castillo A","year":"2008","unstructured":"Loaeza-del-Castillo A, Paz-Pineda F, Oviedo-C\u00e1rdenas E, S\u00e1nchez-Avila F, Vargas-Vor\u00e1ckov\u00e1 F. AST to platelet ratio index (APRI) for the noninvasive evaluation of liver fibrosis. Ann Hepatol. 2008, 7:350-7. 10.1016\/S1665-2681(19)31836-8","journal-title":"Ann Hepatol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2017.3439","article-title":"Screening for preeclampsia: US Preventive Services Task Force Recommendation Statement","volume":"317","author":"Bibbins-Domingo K","year":"2017","unstructured":"Bibbins-Domingo K, Grossman DC, Curry SJ, et al.. Screening for preeclampsia: US Preventive Services Task Force Recommendation Statement. JAMA. 2017, 317:1661-7. 10.1001\/jama.2017.3439","journal-title":"JAMA"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajem.2019.02.014","article-title":"Aspartate-aminotransferase to platelet ratio index score for predicting HELLP syndrome","volume":"38","author":"\u015ea\u015fmaz M\u0130","year":"2020","unstructured":"\u015ea\u015fmaz M\u0130, Ayvaz MA, D\u00fclger AC, Kuday Kayk\u0131s\u0131z EK, G\u00fcven R. Aspartate-aminotransferase to platelet ratio index score for predicting HELLP syndrome. Am J Emerg Med. 2020, 38:459-62. 10.1016\/j.ajem.2019.02.014","journal-title":"Am J Emerg Med"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1053\/jhep.2003.50346","article-title":"A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C","volume":"38","author":"Wai CT","year":"2003","unstructured":"Wai CT, Greenson JK, Fontana RJ, Kalbfleisch JD, Marrero JA, Conjeevaram HS, Lok AS. A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C. Hepatology. 2003, 38:518-26. 10.1053\/jhep.2003.50346","journal-title":"Hepatology"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000018496","article-title":"Diagnostic value of neutrophil-lymphocyte ratio in preeclampsia: a PRISMA-compliant systematic review and meta-analysis","volume":"98","author":"Zheng WF","year":"2019","unstructured":"Zheng WF, Zhan J, Chen A, Ma H, Yang H, Maharjan R. Diagnostic value of neutrophil-lymphocyte ratio in preeclampsia: a PRISMA-compliant systematic review and meta-analysis. Medicine (Baltimore). 2019, 98:e18496. 10.1097\/MD.0000000000018496","journal-title":"Medicine (Baltimore)"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.17772\/gp\/1713","article-title":"Mean platelet volume, neutrophil-lymphocyte ratio and platelet-lymphocyte ratio in severe preeclampsia","volume":"85","author":"Yavuzcan A","year":"2014","unstructured":"Yavuzcan A, Ca\u011flar M, Ust\u00fcn Y, et al.. Mean platelet volume, neutrophil-lymphocyte ratio and platelet-lymphocyte ratio in severe preeclampsia. Ginekol Pol. 2014, 85:197-203. 10.17772\/gp\/1713","journal-title":"Ginekol Pol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/j.htct.2018.08.008","article-title":"A correlation between platelet indices and preeclampsia","volume":"41","author":"Thalor N","year":"2019","unstructured":"Thalor N, Singh K, Pujani M, Chauhan V, Agarwal C, Ahuja R. A correlation between platelet indices and preeclampsia. Hematol Transfus Cell Ther. 2019, 41:129-33. 10.1016\/j.htct.2018.08.008","journal-title":"Hematol Transfus Cell Ther"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1080\/14767058.2017.1410701","article-title":"Are neutrophil\/lymphocyte ratio (NLR), platelet\/lymphocyte ratio (PLR), and\/or mean platelet volume (MPV) clinically useful as predictive parameters for preeclampsia?","volume":"32","author":"Mannaerts D","year":"2019","unstructured":"Mannaerts D, Heyvaert S, De Cordt C, Macken C, Loos C, Jacquemyn Y. Are neutrophil\/lymphocyte ratio (NLR), platelet\/lymphocyte ratio (PLR), and\/or mean platelet volume (MPV) clinically useful as predictive parameters for preeclampsia?. J Matern Fetal Neonatal Med. 2019, 32:1412-9. 10.1080\/14767058.2017.1410701","journal-title":"J Matern Fetal Neonatal Med"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.5603\/GP.2016.0021","article-title":"High first-trimester neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios are indicators for early diagnosis of preeclampsia","volume":"87","author":"Gezer C","year":"2016","unstructured":"Gezer C, Ekin A, Ertas IE, Ozeren M, Solmaz U, Mat E, Taner CE. High first-trimester neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios are indicators for early diagnosis of preeclampsia. Ginekol Pol. 2016, 87:431-5. 10.5603\/GP.2016.0021","journal-title":"Ginekol Pol"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1016\/j.jri.2019.02.001","article-title":"Assessment efficacy of neutrophil-lymphocyte ratio and monocyte-lymphocyte ratio in preeclampsia","volume":"132","author":"Wang J","year":"2019","unstructured":"Wang J, Zhu QW, Cheng XY, et al.. Assessment efficacy of neutrophil-lymphocyte ratio and monocyte-lymphocyte ratio in preeclampsia. J Reprod Immunol. 2019, 132:29-34. 10.1016\/j.jri.2019.02.001","journal-title":"J Reprod Immunol"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.3390\/jcm9092760","article-title":"The relationship between hematological markers of systemic inflammation (neutrophil-to-lymphocyte, platelet-to-lymphocyte, lymphocyte-to-monocyte ratios) and ultrasound disease activity parameters in patients with rheumatoid arthritis","volume":"9","author":"Targo\u0144ska-St\u0119pniak B","year":"2020","unstructured":"Targo\u0144ska-St\u0119pniak B, Zwolak R, Piotrowski M, Grzechnik K, Majdan M. The relationship between hematological markers of systemic inflammation (neutrophil-to-lymphocyte, platelet-to-lymphocyte, lymphocyte-to-monocyte ratios) and ultrasound disease activity parameters in patients with rheumatoid arthritis. J Clin Med. 2020, 9:10.3390\/jcm9092760","journal-title":"J Clin Med"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.3109\/14767058.2014.905910","article-title":"May ratio of neutrophil to lymphocyte be useful in predicting the risk of developing preeclampsia? A pilot study","volume":"28","author":"Kurtoglu E","year":"2015","unstructured":"Kurtoglu E, Kokcu A, Celik H, Tosun M, Malatyalioglu E. May ratio of neutrophil to lymphocyte be useful in predicting the risk of developing preeclampsia? A pilot study. J Matern Fetal Neonatal Med. 2015, 28:97-9. 10.3109\/14767058.2014.905910","journal-title":"J Matern Fetal Neonatal Med"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.7860\/JCDR\/2015\/15397.6833","article-title":"Prediction of preeclampsia by first trimester combined test and simple complete blood count parameters","volume":"9","author":"Kirbas A","year":"2015","unstructured":"Kirbas A, Ersoy AO, Daglar K, Dikici T, Biberoglu EH, Kirbas O, Danisman N. Prediction of preeclampsia by first trimester combined test and simple complete blood count parameters. J Clin Diagn Res. 2015, 9:QC20-3. 10.7860\/JCDR\/2015\/15397.6833","journal-title":"J Clin Diagn Res"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1016\/j.preghy.2016.12.002","article-title":"Neutrophil to lymphocyte ratio, platelet to lymphocyte ratio, mean platelet volume, red cell distribution width and plateletcrit in preeclampsia","volume":"7","author":"Y\u00fccel B","year":"2017","unstructured":"Y\u00fccel B, Ustun B. Neutrophil to lymphocyte ratio, platelet to lymphocyte ratio, mean platelet volume, red cell distribution width and plateletcrit in preeclampsia. Pregnancy Hypertens. 2017, 7:29-32. 10.1016\/j.preghy.2016.12.002","journal-title":"Pregnancy Hypertens"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/162424-is-there-a-predictable-cost-benefit-ratio-in-preeclampsia","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T20:00:39Z","timestamp":1707508839000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/162424-is-there-a-predictable-cost-benefit-ratio-in-preeclampsia"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,27]]},"references-count":25,"URL":"https:\/\/doi.org\/10.7759\/cureus.41051","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,6,27]]}}}